<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Evaluate &#8211; News Journos</title>
	<atom:link href="https://newsjournos.com/tag/evaluate/feed/" rel="self" type="application/rss+xml" />
	<link>https://newsjournos.com</link>
	<description>Independent News and Headlines</description>
	<lastBuildDate>Fri, 11 Jul 2025 13:28:13 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://newsjournos.com/wp-content/uploads/2025/02/cropped-The_News_Journos_Fav-1-32x32.png</url>
	<title>Evaluate &#8211; News Journos</title>
	<link>https://newsjournos.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>FDA to Evaluate Drug Affordability in Streamlining Approval Process</title>
		<link>https://newsjournos.com/fda-to-evaluate-drug-affordability-in-streamlining-approval-process/</link>
					<comments>https://newsjournos.com/fda-to-evaluate-drug-affordability-in-streamlining-approval-process/?noamp=mobile#respond</comments>
		
		<dc:creator><![CDATA[News Editor]]></dc:creator>
		<pubDate>Fri, 11 Jul 2025 13:28:03 +0000</pubDate>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[Approval]]></category>
		<category><![CDATA[Business Ethics]]></category>
		<category><![CDATA[Business Growth]]></category>
		<category><![CDATA[Business News]]></category>
		<category><![CDATA[Business Technology]]></category>
		<category><![CDATA[Consumer Trends]]></category>
		<category><![CDATA[Corporate Finance]]></category>
		<category><![CDATA[Corporate Strategy]]></category>
		<category><![CDATA[drug]]></category>
		<category><![CDATA[Economic Outlook]]></category>
		<category><![CDATA[Entrepreneurship]]></category>
		<category><![CDATA[Evaluate]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Global Business]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Investment Opportunities]]></category>
		<category><![CDATA[Leadership]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Market Trends]]></category>
		<category><![CDATA[Mergers & Acquisitions]]></category>
		<category><![CDATA[process]]></category>
		<category><![CDATA[Retail Business]]></category>
		<category><![CDATA[Small Business]]></category>
		<category><![CDATA[Startups]]></category>
		<category><![CDATA[Streamlining]]></category>
		<category><![CDATA[Supply Chain]]></category>
		<guid isPermaLink="false">https://newsjournos.com/fda-to-evaluate-drug-affordability-in-streamlining-approval-process/</guid>

					<description><![CDATA[<p>This article is published by News Journos</p>
<p>The Food and Drug Administration (FDA) is set to introduce new measures aimed at enhancing drug affordability during the approval process for new treatments. Commissioner Marty Makary announced that drug affordability will be considered when the FDA issues vouchers designed to expedite the approval of certain medications. This shift in criteria aligns with broader national [...]</p>
<p>©2025 News Journos. All rights reserved.</p>
]]></description>
										<content:encoded><![CDATA[<p>This article is published by News Journos</p>
<div id="RegularArticle-ArticleBody-5" data-module="ArticleBody" data-test="articleBody-2" data-analytics="RegularArticle-articleBody-5-2"><span class="HighlightShare-hidden" style="top:0;left:0"/></p>
<div role="region" aria-labelledby="Placeholder-ArticleBody-Video-108170744">
<div role="button" tabindex="0" id="Placeholder-ArticleBody-Video-108170744" class="PlaceHolder-wrapper" data-vilynx-id="7000382069" data-test="VideoPlaceHolder">
<div class="InlineVideo-videoEmbed" id="InlineVideo-0" data-test="InlineVideo">
<div class="InlineVideo-wrapper">
<div class="InlineVideo-inlineThumbnailContainer"><span class="InlineVideo-videoButton"/><span/></div>
</div>
</div>
</div>
</div>
<div class="group">
<p style="text-align:left;">The Food and Drug Administration (FDA) is set to introduce new measures aimed at enhancing drug affordability during the approval process for new treatments. Commissioner <strong>Marty Makary</strong> announced that drug affordability will be considered when the FDA issues vouchers designed to expedite the approval of certain medications. This shift in criteria aligns with broader national goals, including reducing drug prices, as the Trump administration grapples with the complexities surrounding pharmaceutical tariffs and manufacturing.</p>
<p style="text-align:left;">In June, the FDA unveiled a national priority voucher program aimed at shortening drug review times to between one and two months. However, the inclusion of affordability as a critical factor is a new development that could significantly impact both drug manufacturers and consumers. The upcoming changes reflect the administration&#8217;s commitment to ensuring that American patients are not overcharged for essential medications.</p>
</div>
<div class="InlineImage-imageEmbed" id="ArticleBody-InlineImage-108170803" data-test="InlineImage">
<div class="InlineImage-wrapper">
<div>
<p style="text-align:left;">Commissioner of the Food and Drug Administration <strong>Marty Makary</strong> speaks at a news conference on removing synthetic dyes from America&#8217;s food supply, at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. </p>
<p style="text-align:left;">Nathan Posner | Anadolu | Getty Images</p>
</div>
</div>
</div>
<div class="group">
<p style="text-align:left;">Commissioner <strong>Marty Makary</strong> further emphasized that President <strong>Donald Trump</strong> is determined to lower drug prices, expressing dissatisfaction with the current landscape where U.S. drug prices can be exorbitantly higher than those in other developed nations. &#8220;Americans are getting ripped off with drugs that are two, five, ten times higher,&#8221; </p>
<blockquote style="text-align:left;"><p>Makary noted in a recent statement.</p></blockquote>
<p style="text-align:left;">While the intent to prioritize affordability is evident, specifics on how affordability will influence the approval process remain unclear. Typically, prices are determined post-approval, which complicates the assessment of drug affordability at the time of voucher consideration.</p>
<p style="text-align:left;">The FDA’s new program outlines four national priorities that will guide the allocation of the vouchers: addressing health crises in the U.S., delivering innovative cures, addressing unmet public health needs, and enhancing domestic drug manufacturing as a national security issue. Incorporating affordability into this criteria is a significant expansion of the FDA’s prior focus.</p>
<p style="text-align:left;">Reports indicate that discussions around including affordability in the voucher program may date back to earlier this year, underlining the increasing emphasis placed on patient access and drug pricing.</p>
<p style="text-align:left;">A spokesperson for the Department of Health and Human Services confirmed this stance, assuring that affordability will influence the new program and that criteria for eligibility will not be limited to previously mentioned examples.</p>
<p style="text-align:left;">During the announcement, <strong>Makary</strong> provided insights into specific health crises that FDA vouchers could help address, including the need for a breakthrough cure for Type 1 diabetes, advances in neurodegenerative disease treatments, and the development of a universal flu shot that would alleviate the uncertainty of annual vaccine variations. &#8220;We must ask ourselves, why does it take so long to come to market?&#8221; </p>
<blockquote style="text-align:left;"><p>Makary queried.</p></blockquote>
<p style="text-align:left;">In addition, he stressed the urgency of finding effective treatments for stage 4 cancer, a critical stage where the disease has metastasized. The FDA intends to establish a committee responsible for evaluating which products and companies warrant receiving vouchers as part of this pilot initiative aimed at bringing innovative medical solutions to market more efficiently.</p>
<p style="text-align:left;">The FDA plans to start distributing new vouchers this year, with a pilot phase lasting one year. Following this initial trial, there is potential for an increase in the volume of rapid approvals granted to pharmaceutical companies.</p>
<p style="text-align:left;">Economic analysts speculate that this new voucher program could serve as a more effective motivator for drug manufacturers to relocate their operations to the United States compared to the alternative of imposing tariffs on imported pharmaceuticals.</p>
<p style="text-align:left;">Nevertheless, concerns linger regarding the implications of accelerating drug review timelines, especially if they are compressed to as little as 30 days—the fastest time frame in the FDA&#8217;s history. The challenge lies in maintaining rigorous standards while expediting the approval process.</p>
<p style="text-align:left;">Another pressing issue involves potential conflicts of interest, specifically whether the FDA might extend vouchers to firms with political ties to the Trump administration, which could include companies typically subjected to stringent scrutiny by agency officials.</p>
</div>
</div>
<table style="width:100%; text-align:left; border-collapse:collapse;">
<thead>
<tr>
<th style="text-align:left; padding:5px;">
        <strong>Article Subheadings</strong>
      </th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>1)</strong> FDA&#8217;s New Approach to Drug Affordability
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>2)</strong> National Priority Voucher Program Explained
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>3)</strong> Implications of Accelerating Drug Approvals
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>4)</strong> Stakeholder Reactions and Concerns
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>5)</strong> Future of Drug Approval Processes
      </td>
</tr>
</tbody>
</table>
<h3 style="text-align:left;">FDA&#8217;s New Approach to Drug Affordability</h3>
<p style="text-align:left;">The FDA’s newly proposed stance on drug affordability signifies a substantial shift in healthcare policy and the regulatory landscape. As highlighted by Commissioner <strong>Marty Makary</strong>, the inclusion of affordability in the approval criteria underscores the administration’s commitment to ensuring that life-saving medications are accessible and economically viable for American citizens. This initiative aligns with broader national goals to alleviate the financial burden of healthcare in the U.S.</p>
<p style="text-align:left;">This change is particularly pivotal as many Americans continue to face exorbitant drug costs, prompting the need for regulatory adjustments to meet the demands of both patients and the healthcare market. The FDA&#8217;s prioritization of affordability could also reflect a growing recognition of the public&#8217;s voice in healthcare discussions, addressing long-standing criticisms directed toward pharmaceutical companies about price gouging and lack of transparency.</p>
<p style="text-align:left;">Moreover, the implications of this decision reverberate beyond the immediate affordability concerns. It could lead to significant shifts in how pharmaceutical companies determine their pricing strategies, potentially fostering a culture of accountability and accessibility in drug pricing.</p>
<h3 style="text-align:left;">National Priority Voucher Program Explained</h3>
<p style="text-align:left;">The national priority voucher program introduced by the FDA is designed to streamline the drug approval process significantly. With the aim of reducing review times to as little as one or two months, the initiative allows for quicker access to innovative treatments that could address pressing health crises in the United States. The criteria for the program encompass a diverse range of priorities, ensuring that companies working on critical health solutions are recognized and supported.</p>
<p style="text-align:left;">Under this program, the FDA aims to expedite approvals for companies that contribute to national interests, which now explicitly includes affordability. This broadened scope represents a shift toward a more consumer-focused approach while balancing the needs of the healthcare system. The agency’s acknowledgment of affordability as a national priority highlights the urgent need for accessible medications, particularly as chronic illnesses continue to rise across the country.</p>
<p style="text-align:left;">By intertwining drug affordability with national priorities, the FDA signals a commitment to fostering innovation in ways that also prioritize patient welfare. The criteria established by the agency represent a concerted effort to prioritize the health and economic interests of the American population.</p>
<h3 style="text-align:left;">Implications of Accelerating Drug Approvals</h3>
<p style="text-align:left;">The acceleration of drug approvals raises several critical discussions around safety, efficacy, and market availability. As the FDA moves toward potentially allowing drug reviews to take as little as 30 days, the agency must carefully consider the implications of such rapid timelines on public health. Proponents of faster approvals argue that expedited processes could facilitate timely access to life-saving treatments; however, the risks associated with shortening review periods cannot be overlooked.</p>
<p style="text-align:left;">A hastened approval process could lead to insufficient evaluations of new drugs, potentially placing patients at risk if safety standards are compromised. The FDA has historically been cautious in its review process to ensure that all therapeutic effects and side effects are thoroughly assessed before a drug reaches the market.</p>
<p style="text-align:left;">Moreover, balancing speed with thorough scrutiny will be paramount to ensure public trust in the FDA’s regulatory capabilities. Striking this balance becomes crucial as the agency seeks to fulfill its dual responsibility of fostering innovation while safeguarding public health.</p>
<h3 style="text-align:left;">Stakeholder Reactions and Concerns</h3>
<p style="text-align:left;">Reactions from stakeholders, including healthcare advocates, pharmaceutical representatives, and patient advocacy groups, have been varied. While many applaud the FDA&#8217;s efforts to consider affordability and promote timely access to treatments, concerns arise regarding the potential politicization of voucher allocation. Questions have been raised about whether political affiliations may unduly influence which companies receive vouchers, thus undermining the integrity of the FDA&#8217;s approval process.</p>
<p style="text-align:left;">Additionally, advocacy groups emphasize the importance of transparency and fairness in the voucher program. Stakeholders are closely watching to ensure that the process does not favor companies with strong political connections, potentially leading to disparities in treatment availability.</p>
<p style="text-align:left;">The potential conflicts of interest present a significant challenge for the FDA and require robust oversight mechanisms to ensure that the new program achieves its intended outcomes without compromising ethical standards.</p>
<h3 style="text-align:left;">Future of Drug Approval Processes</h3>
<p style="text-align:left;">As the FDA embarks on this new path toward integrating affordability into its drug approval framework, the future of drug approval processes looks to be a pivotal area of evolution in U.S. healthcare. This initiative stands to not only redefine the speed of drug approvals but also the characteristics used to assess eligibility for expedited processes. With the pilot phase initiated this year, stakeholders will be undoubtedly observing its impact closely.</p>
<p style="text-align:left;">The FDA&#8217;s willingness to address the healthcare cost crisis reflects its responsiveness to the needs of the American public, signifying a potential shift toward a more equitable healthcare system. By addressing affordability alongside innovation, the FDA could offer a model for how regulatory bodies can evolve to better meet the changing dynamics of the healthcare landscape.</p>
<p style="text-align:left;">In conclusion, how the FDA navigates these changes will be crucial not just for the agency’s credibility but also for the future of healthcare access and affordability in America. The outcomes of these initiatives could set the stage for how drug markets operate and how patients access essential treatments in the years to come.</p>
<table style="width:100%; text-align:left; border-collapse:collapse;">
<thead>
<tr>
<th style="text-align:left;"><strong>No.</strong></th>
<th style="text-align:left;"><strong>Key Points</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">1</td>
<td style="text-align:left;">The FDA is now considering drug affordability in its voucher program for expedited approvals.</td>
</tr>
<tr>
<td style="text-align:left;">2</td>
<td style="text-align:left;">The national priority voucher program aims to shorten drug review times to one or two months.</td>
</tr>
<tr>
<td style="text-align:left;">3</td>
<td style="text-align:left;">Accelerating drug approvals raises concerns about potential risks to patient safety.</td>
</tr>
<tr>
<td style="text-align:left;">4</td>
<td style="text-align:left;">Concerns exist about the potential politicization of the voucher allocation process.</td>
</tr>
<tr>
<td style="text-align:left;">5</td>
<td style="text-align:left;">The future of drug approval processes could redefine access to affordable healthcare.</td>
</tr>
</tbody>
</table>
<h2 style="text-align:left;">Summary</h2>
<p style="text-align:left;">The FDA&#8217;s announcement regarding its new approach to drug affordability in the approval process represents a significant milestone in healthcare regulation. By emphasizing affordability alongside expedited drug approvals, the agency aims to address pressing concerns about high drug prices faced by American consumers. This initiative reflects a broader commitment to making essential medications accessible, while also navigating the complexities of maintaining rigorous standards for safety and efficacy. As the situation evolves, stakeholders will be closely monitoring how these changes manifest in practice and impact the landscape of drug availability and affordability in the United States.</p>
<h2 style="text-align:left;">Frequently Asked Questions</h2>
<p><strong>Question: Why is drug affordability now a priority for the FDA?</strong></p>
<p style="text-align:left;">Drug affordability has become a priority as the FDA aims to address skyrocketing medication costs that American consumers face, reflecting a commitment to making essential treatments more accessible.</p>
<p><strong>Question: What is the national priority voucher program?</strong></p>
<p style="text-align:left;">The national priority voucher program allows the FDA to expedite drug approvals for companies contributing to U.S. health needs, now including affordability as a criteria.</p>
<p><strong>Question: How might accelerated drug approvals affect patient safety?</strong></p>
<p style="text-align:left;">Accelerated drug approvals raise concerns about potential risks to patient safety, as quicker reviews may lead to insufficient evaluations of drugs before they reach the market.</p>
</div>
<p>©2025 News Journos. All rights reserved.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://newsjournos.com/fda-to-evaluate-drug-affordability-in-streamlining-approval-process/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Experts Evaluate Ron Paul&#8217;s Libertarian Concerns on REAL ID Implementation</title>
		<link>https://newsjournos.com/experts-evaluate-ron-pauls-libertarian-concerns-on-real-id-implementation/</link>
					<comments>https://newsjournos.com/experts-evaluate-ron-pauls-libertarian-concerns-on-real-id-implementation/?noamp=mobile#respond</comments>
		
		<dc:creator><![CDATA[News Editor]]></dc:creator>
		<pubDate>Sat, 03 May 2025 17:12:40 +0000</pubDate>
				<category><![CDATA[Politics]]></category>
		<category><![CDATA[Bipartisan Negotiations]]></category>
		<category><![CDATA[concerns]]></category>
		<category><![CDATA[Congressional Debates]]></category>
		<category><![CDATA[Election Campaigns]]></category>
		<category><![CDATA[Evaluate]]></category>
		<category><![CDATA[Executive Orders]]></category>
		<category><![CDATA[experts]]></category>
		<category><![CDATA[Federal Budget]]></category>
		<category><![CDATA[Healthcare Policy]]></category>
		<category><![CDATA[House of Representatives]]></category>
		<category><![CDATA[Immigration Reform]]></category>
		<category><![CDATA[Implementation]]></category>
		<category><![CDATA[Legislative Process]]></category>
		<category><![CDATA[Libertarian]]></category>
		<category><![CDATA[Lobbying Activities]]></category>
		<category><![CDATA[National Security]]></category>
		<category><![CDATA[Party Platforms]]></category>
		<category><![CDATA[Pauls]]></category>
		<category><![CDATA[Political Fundraising]]></category>
		<category><![CDATA[Presidential Agenda]]></category>
		<category><![CDATA[Public Policy]]></category>
		<category><![CDATA[Real]]></category>
		<category><![CDATA[Ron]]></category>
		<category><![CDATA[Senate Hearings]]></category>
		<category><![CDATA[Supreme Court Decisions]]></category>
		<category><![CDATA[Tax Legislation]]></category>
		<category><![CDATA[Voter Turnout]]></category>
		<guid isPermaLink="false">https://newsjournos.com/experts-evaluate-ron-pauls-libertarian-concerns-on-real-id-implementation/</guid>

					<description><![CDATA[<p>This article is published by News Journos</p>
<p>As the deadline for obtaining a REAL ID approaches, shifting perspectives raise important questions regarding its implications for national security and civil liberties. Originally enacted in response to the September 11 attacks, the REAL ID Act mandates enhanced security features for identification documents used in federal contexts. While supporters argue it is a necessary measure [...]</p>
<p>©2025 News Journos. All rights reserved.</p>
]]></description>
										<content:encoded><![CDATA[<p>This article is published by News Journos</p>
<p style="text-align:left;">As the deadline for obtaining a REAL ID approaches, shifting perspectives raise important questions regarding its implications for national security and civil liberties. Originally enacted in response to the September 11 attacks, the REAL ID Act mandates enhanced security features for identification documents used in federal contexts. While supporters argue it is a necessary measure for identification and security, critics warn of potential overreach and violations of personal freedoms. This article explores the ongoing debate surrounding the REAL ID policy, its history, and what individuals need to know moving forward.</p>
<table style="width:100%; text-align:left; border-collapse:collapse;">
<thead>
<tr>
<th style="text-align:left; padding:5px;">
        <strong>Article Subheadings</strong>
      </th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>1)</strong> Understanding REAL ID: Background and Purpose
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>2)</strong> Advocates of REAL ID: Promoting National Security
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>3)</strong> Concerns about Personal Liberty and Privacy
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>4)</strong> The Implementation Challenges of REAL ID
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>5)</strong> Future Considerations: What Citizens Should Know
      </td>
</tr>
</tbody>
</table>
<h3 style="text-align:left;">Understanding REAL ID: Background and Purpose</h3>
<p style="text-align:left;">The REAL ID Act was instituted by Congress in 2005 as a response to the tragic September 11 attacks. The primary purpose of this initiative was to enhance the security of state-issued identification documents to prevent terrorism and other forms of illegal activity. The legislation established federal standards for producing identification that would be required for boarding commercial flights and accessing federal facilities, including courthouses and military bases. The law effectively mandates that states meet specific criteria regarding the security features of IDs, creating a uniform standard across the country&#8230;</p>
<h3 style="text-align:left;">Advocates of REAL ID: Promoting National Security</h3>
<p style="text-align:left;">Supporters of the REAL ID movement, including several national security experts, argue that it enhances identification procedures to combat terrorism. <strong>Simon Hankinson</strong>, a senior fellow at the Heritage Foundation, notes that tightening ID requirements can significantly limit the ability of individuals with questionable documentation to travel freely within the country. They emphasize the examples from the 9/11 attacks, where several terrorists held valid state-issued IDs, highlighting vulnerabilities that REAL ID seeks to address&#8230;</p>
<h3 style="text-align:left;">Concerns about Personal Liberty and Privacy</h3>
<p style="text-align:left;">Critics assert that REAL ID poses a substantial threat to personal liberties, likening the policy to a national ID system that could treat citizens as suspects rather than law-abiding individuals. <strong>Jim Harper</strong>, a senior fellow at the American Enterprise Institute, raises alarm about the potential for governmental overreach, reminding us of historical abuses associated with centralized identification systems. The argument is that by entering citizens into a national database, we create an environment where privacy is compromised, and collective judgment may overshadow individual rights&#8230;</p>
<h3 style="text-align:left;">The Implementation Challenges of REAL ID</h3>
<p style="text-align:left;">Challenges surrounding the implementation of REAL ID have persisted since its inception, with multiple delays and extensions over the years. Originally slated for full implementation in 2008, various administrations have pushed the deadline forward, with the most recent cutoff set for May 7. Many states are struggling to meet these requirements, especially as they deal with additional complications like marriage name changes and differing state regulations. Public readiness is a key concern as governmental agencies gear up for enforcement, facing a populace that may not fully understand the implications of not having compliant documentation&#8230;</p>
<h3 style="text-align:left;">Future Considerations: What Citizens Should Know</h3>
<p style="text-align:left;">As the deadline draws near, citizens are faced with questions about their options and the necessity of obtaining a REAL ID. While many will be required to comply for travel and access to federal facilities, there are still alternate forms of identification available for individuals who choose not to participate in the REAL ID system. It is crucial for citizens to weigh the benefits versus the potential drawbacks according to their personal circumstances. Ultimately, the choice of whether to obtain a REAL ID lies with the individual, and understanding the implications is vital&#8230;</p>
<table style="width:100%; text-align:left;">
<thead>
<tr>
<th style="text-align:left;"><strong>No.</strong></th>
<th style="text-align:left;"><strong>Key Points</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">1</td>
<td style="text-align:left;">The REAL ID Act necessitates enhanced security features for state-issued IDs.</td>
</tr>
<tr>
<td style="text-align:left;">2</td>
<td style="text-align:left;">Supporters argue that REAL ID is essential for national security and controlling illegal activities.</td>
</tr>
<tr>
<td style="text-align:left;">3</td>
<td style="text-align:left;">Critics express concern over privacy violations and the treatment of citizens as potential criminals.</td>
</tr>
<tr>
<td style="text-align:left;">4</td>
<td style="text-align:left;">Challenges persist regarding the implementation and public readiness ahead of the May 7 deadline.</td>
</tr>
<tr>
<td style="text-align:left;">5</td>
<td style="text-align:left;">Citizens must weigh their options regarding REAL ID compliance based on personal circumstances.</td>
</tr>
</tbody>
</table>
<h2 style="text-align:left;">Summary</h2>
<p style="text-align:left;">As the deadline for the REAL ID implementation approaches, the ongoing debate raises fundamental questions about security, privacy, and personal freedoms. Advocates for REAL ID see it as a necessary measure to bolster national security, while opponents argue it encroaches upon individual liberties and establishes a worrying precedent for government control. Citizens are encouraged to actively engage in this conversation, stay informed, and consider their options carefully as they navigate the complex implications of this policy.</p>
<h2 style="text-align:left;">Frequently Asked Questions</h2>
<p><strong>Question: What is REAL ID?</strong></p>
<p style="text-align:left;">REAL ID is a federal law mandating that state-issued identification meet specific security standards.</p>
<p><strong>Question: When is the deadline for obtaining a REAL ID?</strong></p>
<p style="text-align:left;">The current deadline for obtaining a REAL ID is May 7, 2025, after which compliant identification will be necessary for specific federal purposes.</p>
<p><strong>Question: How does REAL ID affect individual privacy?</strong></p>
<p style="text-align:left;">Critics argue that REAL ID creates a national database that could compromise individual privacy and treat citizens as suspects.</p>
<p>©2025 News Journos. All rights reserved.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://newsjournos.com/experts-evaluate-ron-pauls-libertarian-concerns-on-real-id-implementation/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Americans Evaluate Trump’s First 100 Days of Second Term Amid Key Headlines</title>
		<link>https://newsjournos.com/americans-evaluate-trumps-first-100-days-of-second-term-amid-key-headlines/</link>
					<comments>https://newsjournos.com/americans-evaluate-trumps-first-100-days-of-second-term-amid-key-headlines/?noamp=mobile#respond</comments>
		
		<dc:creator><![CDATA[News Editor]]></dc:creator>
		<pubDate>Wed, 30 Apr 2025 12:23:56 +0000</pubDate>
				<category><![CDATA[U.S. News]]></category>
		<category><![CDATA[Americans]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Crime]]></category>
		<category><![CDATA[days]]></category>
		<category><![CDATA[Economy]]></category>
		<category><![CDATA[Education]]></category>
		<category><![CDATA[Elections]]></category>
		<category><![CDATA[Environmental Issues]]></category>
		<category><![CDATA[Evaluate]]></category>
		<category><![CDATA[headlines]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Immigration]]></category>
		<category><![CDATA[key]]></category>
		<category><![CDATA[Natural Disasters]]></category>
		<category><![CDATA[Politics]]></category>
		<category><![CDATA[Public Policy]]></category>
		<category><![CDATA[Social Issues]]></category>
		<category><![CDATA[Supreme Court]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Term]]></category>
		<category><![CDATA[Trumps]]></category>
		<category><![CDATA[White House]]></category>
		<guid isPermaLink="false">https://newsjournos.com/americans-evaluate-trumps-first-100-days-of-second-term-amid-key-headlines/</guid>

					<description><![CDATA[<p>This article is published by News Journos</p>
<p>In a recent public address in Michigan, former President Donald Trump reflected on the first 100 days of his current term, enlightening the audience on the challenges faced and the steps taken to navigate them. Concurrently, the administration has released a list of purported &#8220;hoaxes&#8221; propagated by media outlets and critics. The atmosphere is charged [...]</p>
<p>©2025 News Journos. All rights reserved.</p>
]]></description>
										<content:encoded><![CDATA[<p>This article is published by News Journos</p>
<p style="text-align:left;">In a recent public address in Michigan, former President <strong>Donald Trump</strong> reflected on the first 100 days of his current term, enlightening the audience on the challenges faced and the steps taken to navigate them. Concurrently, the administration has released a list of purported &#8220;hoaxes&#8221; propagated by media outlets and critics. The atmosphere is charged with heightened political dialogue as various figures in the media and politics continue to comment on Trump&#8217;s tenure. Public sentiment is visibly varied, highlighting a backdrop of intense partisan divisions.</p>
<table style="width:100%; text-align:left; border-collapse:collapse;">
<thead>
<tr>
<th style="text-align:left; padding:5px;">
        <strong>Article Subheadings</strong>
      </th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>1)</strong> Former President Trump&#8217;s Highlights in Michigan
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>2)</strong> Public and Political Reactions to Trump&#8217;s First 100 Days
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>3)</strong> The Role of Media in Shaping Public Perception
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>4)</strong> Analysis of Trump&#8217;s Ongoing Political Influence
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>5)</strong> Future Prospects for Trump&#8217;s Reelection Campaign
      </td>
</tr>
</tbody>
</table>
<h3 style="text-align:left;">Former President Trump&#8217;s Highlights in Michigan</h3>
<p style="text-align:left;">During his address in Michigan, <strong>Donald Trump</strong> elaborated on the significant milestones achieved in his first 100 days, emphasizing the importance of policy initiatives that are set to benefit the American populace. The rally took place on <strong>Date</strong>, where he motivated his supporters with anecdotes reflecting his administration’s achievements.</p>
<p style="text-align:left;">Trump consistently referred to economic growth and job creation as cornerstones of his administration. &#8220;We&#8217;ve created more jobs than ever before,&#8221; he stated, highlighting a downward trend in unemployment rates. The location of the rally, a notable swing state, was chosen deliberately to engage potential voters ahead of the upcoming election cycle. Enthusiasm was palpable as supporters cheered numerous times throughout his remarks.</p>
<p style="text-align:left;">The former president&#8217;s focus was not only on success stories but also on the challenges faced, including criticism from political opponents and media scrutiny. He portrayed himself as a champion of working-class Americans, suggesting that his administration&#8217;s efforts were tailored to uplift those who felt left behind. Observers noted his flair for connection, as he recounted personal stories that resonated with the audience, solidifying his rapport.</p>
<h3 style="text-align:left;">Public and Political Reactions to Trump&#8217;s First 100 Days</h3>
<p style="text-align:left;">Public reaction to Trump&#8217;s first 100 days has been mixed, with ardent supporters praising his focus on job creation and economic growth, while critics argue that his administration has failed to address vital social issues. According to various polls, a significant portion of the American public remains divided along partisan lines regarding the success of his recent policies.</p>
<p style="text-align:left;">Prominent political figures have commented on Trump&#8217;s performance from both sides of the aisle. Some Republican leaders have expressed support for his policies, stressing that the core objectives of economic recovery are paramount. Conversely, Democratic leaders have raised concerns regarding the rise in divisive rhetoric, highlighting bipartisanship as essential for tackling pressing issues like health care and education reform.</p>
<p style="text-align:left;">The discourse surrounding Trump’s performance resonates particularly with swing voters, who are crucial in elections. Local community leaders in Michigan emphasized the need for constructive dialogue that transcends political affiliations, advocating for solutions that can foster community development. The upcoming midterms will likely serve as a litmus test for public sentiment towards Trump&#8217;s leadership and policies.</p>
<h3 style="text-align:left;">The Role of Media in Shaping Public Perception</h3>
<p style="text-align:left;">In response to Trump&#8217;s criticism of media outlets as purveyors of misinformation, the White House has released a comprehensive list documenting claims they label as &#8220;hoaxes.&#8221; This strategic move aims to counter narratives that the administration perceives as damaging to their credibility. The ongoing feud with various media organizations reflects a broader trend of distrust in traditional news sources amid increasing misinformation.</p>
<p style="text-align:left;">Media analysts note that the relationship between political figures and the press has become more contentious. Reports indicate that trust in media varies significantly among political affiliations, with many Trump supporters characterizing coverage of his administration as biased. This media landscape poses challenges for constituents attempting to discern factual reporting from partisan commentary.</p>
<p style="text-align:left;">As a result, media institutions have had to adapt their strategies, ensuring transparency and factual accuracy to maintain credibility. Initiatives aimed at educational programs for improving media literacy among the public have gained traction, with advocates arguing that informed citizens are essential for a functioning democracy. The upcoming election cycle will provide further insights into how these dynamics evolve.</p>
<h3 style="text-align:left;">Analysis of Trump&#8217;s Ongoing Political Influence</h3>
<p style="text-align:left;">Despite leaving office, Trump&#8217;s impact on the Republican Party and the broader political landscape remains profound. Analysts assert that his influence continues to shape the party&#8217;s agenda, as many Republican candidates seek to align themselves with his vision. Events such as rallies and public speaking engagements indicate a strategy designed to maintain visibility and sway over party politics.</p>
<p style="text-align:left;">Trump&#8217;s endorsements carry significant weight in primary elections, affording him continued leverage in candidate selection and party direction. Observers anticipate that he may leverage this power to advocate for policies aligned with his vision in future legislative discussions. Furthermore, the ongoing discussion around potential primary challengers suggests a complicated landscape ahead for the GOP.</p>
<p style="text-align:left;">The backdrop of Trump&#8217;s persistent persona has engendered discussions about the potential future of the Republican Party, raising questions on the balance between traditional conservativism and the more populist approach that Trump espouses. As political analysts continue to examine the implications of this shift, citizens are left to navigate an increasingly complex political arena.</p>
<h3 style="text-align:left;">Future Prospects for Trump&#8217;s Reelection Campaign</h3>
<p style="text-align:left;">Looking ahead, Trump has announced intentions to pursue reelection in the next presidential election. Observers have noted that his campaign strategy remains reliant on energizing his core base while attempting to reach out to undecided voters. With upcoming primaries on the horizon, strategists are working diligently to bolster campaign efforts across various states.</p>
<p style="text-align:left;">The challenges ahead include addressing lingering controversies and successfully framing his term as a period of achievement unique in its emphasis on economic growth and policy reform. Many analysts assert that Trump&#8217;s campaign will need to effectively communicate how his policies have tangibly benefited everyday Americans.</p>
<p style="text-align:left;">Potential challengers within the party will also create complex dynamics as the election approaches, shaping narrative strategies for his campaign. It will be imperative for Trump to pivot from his past presidency&#8217;s controversies and focus on constructive messaging that resonates with a wider audience. Observers speculate that the outcome of the midterm elections will offer insights into the trajectory of Trump&#8217;s influence and the GOP&#8217;s direction.</p>
<table style="width:100%; text-align:left;">
<thead>
<tr>
<th style="text-align:left;"><strong>No.</strong></th>
<th style="text-align:left;"><strong>Key Points</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">1</td>
<td style="text-align:left;">Trump highlighted key achievements during his address in Michigan.</td>
</tr>
<tr>
<td style="text-align:left;">2</td>
<td style="text-align:left;">Public reaction remains sharply divided along party lines.</td>
</tr>
<tr>
<td style="text-align:left;">3</td>
<td style="text-align:left;">The administration&#8217;s release of a &#8220;hoaxes&#8221; list reflects ongoing conflicts with the media.</td>
</tr>
<tr>
<td style="text-align:left;">4</td>
<td style="text-align:left;">Trump&#8217;s influence continues to shape the GOP and candidate direction.</td>
</tr>
<tr>
<td style="text-align:left;">5</td>
<td style="text-align:left;">Future campaign strategies will focus on reenergizing support and addressing controversies.</td>
</tr>
</tbody>
</table>
<h2 style="text-align:left;">Summary</h2>
<p style="text-align:left;">As Trump reflects on the first 100 days of his presidency, the American political landscape remains volatile and divided. His public addresses continue to galvanize supporters while facing criticism from opponents and the media. With upcoming elections on the horizon, the impact of his leadership will be closely monitored as both supporters and critics seek clarity on the country’s future direction.</p>
<h2 style="text-align:left;">Frequently Asked Questions</h2>
<p><strong>Question: What are the main accomplishments Trump claimed during his address in Michigan?</strong></p>
<p style="text-align:left;">Trump highlighted significant job creation and economic growth as vital achievements of his administration.</p>
<p><strong>Question: How has public sentiment reacted to Trump&#8217;s current administration?</strong></p>
<p style="text-align:left;">Public sentiment remains sharply divided, with supporters praising his initiatives while critics raise concerns regarding social issues and divisive rhetoric.</p>
<p><strong>Question: What role does the media play in shaping public perception of Trump&#8217;s presidency?</strong></p>
<p style="text-align:left;">The media plays a significant role, with varying trust levels among political affiliations, impacting how Trump&#8217;s policies are perceived and discussed by the public.</p>
<p>©2025 News Journos. All rights reserved.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://newsjournos.com/americans-evaluate-trumps-first-100-days-of-second-term-amid-key-headlines/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Economists Evaluate Trump&#8217;s Tariff Policies After 100 Days</title>
		<link>https://newsjournos.com/economists-evaluate-trumps-tariff-policies-after-100-days/</link>
					<comments>https://newsjournos.com/economists-evaluate-trumps-tariff-policies-after-100-days/?noamp=mobile#respond</comments>
		
		<dc:creator><![CDATA[News Editor]]></dc:creator>
		<pubDate>Wed, 30 Apr 2025 02:25:08 +0000</pubDate>
				<category><![CDATA[Politics]]></category>
		<category><![CDATA[Bipartisan Negotiations]]></category>
		<category><![CDATA[Congressional Debates]]></category>
		<category><![CDATA[days]]></category>
		<category><![CDATA[Economists]]></category>
		<category><![CDATA[Election Campaigns]]></category>
		<category><![CDATA[Evaluate]]></category>
		<category><![CDATA[Executive Orders]]></category>
		<category><![CDATA[Federal Budget]]></category>
		<category><![CDATA[Healthcare Policy]]></category>
		<category><![CDATA[House of Representatives]]></category>
		<category><![CDATA[Immigration Reform]]></category>
		<category><![CDATA[Legislative Process]]></category>
		<category><![CDATA[Lobbying Activities]]></category>
		<category><![CDATA[National Security]]></category>
		<category><![CDATA[Party Platforms]]></category>
		<category><![CDATA[Policies]]></category>
		<category><![CDATA[Political Fundraising]]></category>
		<category><![CDATA[Presidential Agenda]]></category>
		<category><![CDATA[Public Policy]]></category>
		<category><![CDATA[Senate Hearings]]></category>
		<category><![CDATA[Supreme Court Decisions]]></category>
		<category><![CDATA[tariff]]></category>
		<category><![CDATA[Tax Legislation]]></category>
		<category><![CDATA[Trumps]]></category>
		<category><![CDATA[Voter Turnout]]></category>
		<guid isPermaLink="false">https://newsjournos.com/economists-evaluate-trumps-tariff-policies-after-100-days/</guid>

					<description><![CDATA[<p>This article is published by News Journos</p>
<p>In the wake of President Donald Trump&#8217;s aggressive trade policies, the economic landscape appears increasingly fraught with uncertainty. Having recommitted to a second term based on promises to stabilize prices and create jobs, Trump&#8217;s recent tariff announcements have left economists questioning their efficacy. Analysts express concerns that these tariffs, especially those impacting trade with China, [...]</p>
<p>©2025 News Journos. All rights reserved.</p>
]]></description>
										<content:encoded><![CDATA[<p>This article is published by News Journos</p>
<p style="text-align:left;">In the wake of President Donald Trump&#8217;s aggressive trade policies, the economic landscape appears increasingly fraught with uncertainty. Having recommitted to a second term based on promises to stabilize prices and create jobs, Trump&#8217;s recent tariff announcements have left economists questioning their efficacy. Analysts express concerns that these tariffs, especially those impacting trade with China, could escalate tensions, freeze billions in international trade, and jeopardize the U.S. economy as recession warnings loom.</p>
<table style="width:100%; text-align:left; border-collapse:collapse;">
<thead>
<tr>
<th style="text-align:left; padding:5px;">
        <strong>Article Subheadings</strong>
      </th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>1)</strong> Overview of Tariff Announcements
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>2)</strong> Short-term Economic Impact
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>3)</strong> Potential For Deescalation
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>4)</strong> Predominantly Affected Demographics
      </td>
</tr>
<tr>
<td style="text-align:left; padding:5px;">
        <strong>5)</strong> Future Economic Considerations
      </td>
</tr>
</tbody>
</table>
<h3 style="text-align:left;">Overview of Tariff Announcements</h3>
<p style="text-align:left;">President <strong>Donald Trump</strong> recently declared a new framework for tariffs, which he famously dubbed &#8220;Liberation Day,&#8221; on April 2, 2025. This announcement included a standard universal baseline tariff of 10%, along with plans to increase tariffs on a multitude of countries, with a particular focus on <strong>China</strong>. During his campaign and initial days in office, Trump positioned himself as the &#8220;Tariff Man,&#8221; seeking to utilize tariffs as a tool to reign in imports and bolster the American economy.</p>
<p style="text-align:left;">Economists express concern that these tariffs are politically motivated and potentially damaging. Many have suggested that the initial shock to the economy from these tariffs could be detrimental, emphasizing that trade with advantageous neighbors should ideally focus on cooperation rather than strife. Trump&#8217;s assertion that he would facilitate better deals through these tariffs appears counterproductive to some analysts.</p>
<h3 style="text-align:left;">Short-term Economic Impact</h3>
<p style="text-align:left;">Following the tariff announcement, stock markets reacted dramatically, experiencing one of the most significant single-day losses in the S&#038;P 500 since World War II. This downward trend raised immediate concerns among investors and consumers about what these tariffs could mean for the U.S. economy in broader terms. <strong>Justin Wolfers</strong>, an economist at the University of Michigan, indicated that the likelihood of recession under the Trump administration has surged from about 10% to an alarming 55% in light of the current climate.</p>
<p style="text-align:left;">While the administration subsequently paused some tariffs for 90 days in a bid to negotiate trade deals, the consequence has been a certain level of panic among businesses and consumers alike. Already, prices on import-dependent goods have begun to rise in anticipation of increased costs, which analysts believe will exacerbate inflation across various sectors. Experts argue that the disruptive nature of these tariffs could lead to long-term changes in global supply chains and a slowdown in economic growth.</p>
<h3 style="text-align:left;">Potential For Deescalation</h3>
<p style="text-align:left;">The question now looms: will <strong>Trump</strong> backtrack on these tariffs? Analysts highlight that Trump&#8217;s propensity to alter his position often depends heavily on market reactions and public opinion. Currently, few indications point to the likelihood of tangible benefits from these tariffs. Experts warn that countries affected by these tariffs may decide to limit trade with the U.S., which could further isolate the American economy.</p>
<p style="text-align:left;"><strong>Gary Clyde Hufbauer</strong>, a non-resident fellow at the Peterson Institute for International Economics, noted that if the tariffs remain unchanged, the prospect of nearly halting trade between the U.S. and China could become a reality by mid-year. This would threaten over $650 billion in annual trade and could have long-lasting repercussions for global commerce.</p>
<h3 style="text-align:left;">Predominantly Affected Demographics</h3>
<p style="text-align:left;">The impact of these tariffs is poised to ripple across various demographics, particularly affecting working-class families who primarily rely on imported goods. While Trump maintains that tariffs are designed to help American workers by targeting competitors, the reality is that the financial burden often falls on the consumers themselves. <strong>David H. Feldman</strong>, an economist from William &#038; Mary College, emphasized that any price increases triggered by these tariffs would predominantly impact middle-class Americans who may already be facing challenging economic conditions.</p>
<p style="text-align:left;">Experts clarify that Trump&#8217;s views on the trade deficit are based on misconceptions about the broader economic benefits of American imports. For every dollar spent on imports, the U.S. also receives valuable goods in return, creating a circular economic exchange that benefits consumers immensely.</p>
<h3 style="text-align:left;">Future Economic Considerations</h3>
<p style="text-align:left;">As situations unfold, the uncertainty stemming from Trump&#8217;s current policies could stifle investments in trade-exposed industries, leading to broader economic decline. Concerns are growing regarding potential market instability, particularly if investors begin to pursue &#8220;flight to cash&#8221; strategies reminiscent of past economic crises, such as the one that occurred in 2008. Should consumer confidence tumble, the risks of recession could become all the more pronounced.</p>
<p style="text-align:left;">Looking ahead, many economists speculate that there may be some retreat from the proposed 145% tariffs on China, particularly if there’s notable backlash from the market or if poll numbers begin to dwindle. However, the road to deescalation remains fraught with uncertainties, leaving many to ponder how the situation might unfold.</p>
<table style="width:100%; text-align:left;">
<thead>
<tr>
<th style="text-align:left;"><strong>No.</strong></th>
<th style="text-align:left;"><strong>Key Points</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">1</td>
<td style="text-align:left;">Trump&#8217;s trade policies have raised concerns of a potential economic recession.</td>
</tr>
<tr>
<td style="text-align:left;">2</td>
<td style="text-align:left;">Stock market volatility has surged following the announcement of new tariffs.</td>
</tr>
<tr>
<td style="text-align:left;">3</td>
<td style="text-align:left;">The tariffs could disproportionately impact working- and middle-class Americans.</td>
</tr>
<tr>
<td style="text-align:left;">4</td>
<td style="text-align:left;">Economists warn about the long-term consequences of uncertainty on investment.</td>
</tr>
<tr>
<td style="text-align:left;">5</td>
<td style="text-align:left;">Future steps regarding tariffs will depend on market reactions and public sentiment.</td>
</tr>
</tbody>
</table>
<h2 style="text-align:left;">Summary</h2>
<p style="text-align:left;">The implications of Trump&#8217;s second term are becoming increasingly apparent as his proposed tariffs face backlash from economists and the public alike. While aiming to shift trade dynamics in favor of American workers, the risks of heightened tariffs may very well destabilize the economy, leading to repercussions that extend well beyond U.S. borders. As uncertainty mounts, the upcoming months will be pivotal in determining both the success of these policies and their impact on consumer welfare and economic health.</p>
<h2 style="text-align:left;">Frequently Asked Questions</h2>
<p><strong>Question: What are the proposed tariffs aimed at?</strong></p>
<p style="text-align:left;">The proposed tariffs are aimed at reducing imports from countries like China to protect American jobs and lower the trade deficit.</p>
<p><strong>Question: How have the tariffs affected the stock market?</strong></p>
<p style="text-align:left;">The announcement of the tariffs has led to significant fluctuations in the stock market, including one of the largest single-day losses since WWII.</p>
<p><strong>Question: Who will be most impacted by these tariffs?</strong></p>
<p style="text-align:left;">Working- and middle-class Americans who rely on imported goods will likely face the most significant financial impacts from the tariffs.</p>
<p>©2025 News Journos. All rights reserved.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://newsjournos.com/economists-evaluate-trumps-tariff-policies-after-100-days/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
